Webinars

Our informative webinars are in partnership with the Journal of Parkinson’s Disease and Parkinson’s Movement.

These quarterly webinars are each chaired by Professor Patrick Brundin (Van Andel Research Institute) who is joined by a different panel of experts discussing important topics and related research within the Parkinson's community.

Re-watch the webinars here...

Upcoming Webinar: Neurotrophic Factors and Parkinson's

Chaired by Prof. Patrik Brundin, this expert webinar panel includes: Dr. Howard Federoff - Professor of Neurology and Neuroscience, University of California; Prof. Mart Saarma - University of Helsinki and Lyndsey Isaacs - Trustee, The Cure Parkinson's Trust. Read more

Webinar - Inflammation in Parkinson's

Once again chaired by Van Andel Institute’s Professor Patrik Brundin - this panel discusses the topic of 'Inflammation in Parkinson's'. Read more

Webinar - Exercise and Parkinson's

Re-watch our webinar discussing recent publications around the theme of exercise in Parkinson’s. Read more

Webinar - Dyskinesia in Parkinson's

Chair Professor Patrik Brundin is joined by Professor Ray Chaudhuri, Professor Angela Cenci Nilsson and patient advocate Martin Taylor as they discuss recent publications around the theme of 'Dyskinesias in Parkinson’s.' Read more

Webinar - How Does Parkinson’s Disease Begin? Neuroanatomical Pathways, Prions and Histology.

The panel discuss the paper 'How Does Parkinson’s Disease Begin? Perspectives on Neuroanatomical Pathways, Prions, and Histology' by Professor Per Borghammer Read more

Webinar - Does Exenatide reduce Non-motor Symptoms in Parkinson’s?

Professor Brundin is joined by Professor Tom Foltynie who led the exenatide trial... Read more

Webinar - Sleep and Parkinson’s Disease

Professor Patrik Brundin is joined by a panel of experts discussing ‘Sleep and Parkinson’s Disease’. Read more

Webinar - Targeting the Genetics of Parkinson's

Professor Patrik Brundin leads a panel discussing the genetics of Parkinson's... Read more

Webinar - Stem Cell (Cell Replacement) Therapy

This webinar focuses on developments in the field of stem cell therapy for Parkinson's... Read more

Latest

Nerve Growth Factors and Parkinson's

For some considerable time CPT has been interested in nerve growth factors or 'neurotrophic' factors for Parkinson's. GDNF, CDNF and C-CDNF are three interesting candidates and our research work within this field continues with drive and urgency.

Emergency Medical Consultant Sketches to Raise Funds

Dr. Johnny Acheson is an Emergency Medical Consultant who is also living with Parkinson’s. Johnny has created sketches to fundraise and to educate about Parkinson’s and depict the humorous side of working in emergency medicine!

CPT ‘Raid Alpine’ Cycle Challenge becomes ‘Raid Local’!

Over 40 cyclists including Mike Tindall and Iain Balshaw, will set off independently on 28 June to tackle what would have been the toughest day on the 'Raid Alpine' ride - but instead, they'll be doing this around their local area!

3P - Post Doc Seminar - 25 June

Join Willemieke Kouwenhoven presenting on 'Vglut2 expression in dopamine neurons contributes to post-lesional striatal reinnervation' and Benoît Delignat-Lavaud discussing 'Mechanisms of somatodendric dopamine release and its contributions to post-lesional plasticity in a PD model”.

Breakthrough in stem cell treatment for Parkinson's

In a major breakthrough for the treatment of Parkinson's, researchers working with laboratory rats show it is possible to make dopamine cells from embryonic stem cells and transplant them into the brain.

Tom Isaacs

We are devastated to announce that Tom Isaacs, President and Co-founder of The Cure Parkinson’s Trust (CPT) died on Wednesday morning (31st May). Tom’s passing was unexpected and swift.

New Evidence Suggests Parkinson's Might Not Start in The Brain

A new study adds to a raft of new evidence which suggests Parkinson's starts in the gut...

Science news

Read the latest Parkinson's science and research news here.

Trials - Repurposed Drugs

Our International Linked Clinical Trials initiative (iLCT) identifies potential new treatments to slow, stop or reverse Parkinson’s disease by 'repurposing' or repositioning drugs that are approved to treat other conditions.

Apply for Funding

The NAC Trial - the facts

Our story

Diabetes Drug Potential Disease-Modifying Therapy

The study, published in The Lancet and funded by The Michael J. Fox Foundation for Parkinson’s Research (MJFF), supported by CPT found that people with Parkinson’s treated with Exenatide for one year performed better in motor tests than those on placebo.